JP2012524034A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524034A5
JP2012524034A5 JP2012505091A JP2012505091A JP2012524034A5 JP 2012524034 A5 JP2012524034 A5 JP 2012524034A5 JP 2012505091 A JP2012505091 A JP 2012505091A JP 2012505091 A JP2012505091 A JP 2012505091A JP 2012524034 A5 JP2012524034 A5 JP 2012524034A5
Authority
JP
Japan
Prior art keywords
solution
relaxation
concentration
skinning
loading
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012505091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524034A (ja
JP5847073B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/002343 external-priority patent/WO2010118878A1/en
Publication of JP2012524034A publication Critical patent/JP2012524034A/ja
Publication of JP2012524034A5 publication Critical patent/JP2012524034A5/ja
Application granted granted Critical
Publication of JP5847073B2 publication Critical patent/JP5847073B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012505091A 2009-04-16 2010-04-16 筋機能増強ペプチド Expired - Fee Related JP5847073B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16996209P 2009-04-16 2009-04-16
US61/169,962 2009-04-16
PCT/EP2010/002343 WO2010118878A1 (en) 2009-04-16 2010-04-16 Muscle function enhancing peptide

Publications (3)

Publication Number Publication Date
JP2012524034A JP2012524034A (ja) 2012-10-11
JP2012524034A5 true JP2012524034A5 (enExample) 2013-05-16
JP5847073B2 JP5847073B2 (ja) 2016-01-20

Family

ID=42226606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012505091A Expired - Fee Related JP5847073B2 (ja) 2009-04-16 2010-04-16 筋機能増強ペプチド

Country Status (7)

Country Link
US (1) US9428564B2 (enExample)
EP (1) EP2419119B1 (enExample)
JP (1) JP5847073B2 (enExample)
CN (1) CN102395377B (enExample)
CA (1) CA2756249C (enExample)
ES (1) ES2638043T3 (enExample)
WO (1) WO2010118878A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2814967C (en) 2010-10-20 2020-07-28 Universitaet Heidelberg Short peptides for enhancing muscle function
US10792329B2 (en) 2013-10-01 2020-10-06 Ruprecht-Karls-Universität Heidelberg S100 based treatment of cardiac power failure
CN117589740B (zh) * 2024-01-04 2025-02-11 南京市产品质量监督检验院(南京市质量发展与先进技术应用研究院) 一种高通量快速检测和评估化合物骨骼肌毒性的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553929B2 (en) * 1994-06-13 2009-06-30 Vanderbilt University Cell permeable peptides for inhibition of inflammatory reactions and methods of use
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
DE19915485A1 (de) * 1999-04-07 2000-10-19 Hugo A Katus Therapie der Herzinsuffizienz

Similar Documents

Publication Publication Date Title
JP2015522045A5 (enExample)
JP2011093937A5 (enExample)
JP2013539946A5 (enExample)
JP2012525416A5 (enExample)
JP2011026329A5 (enExample)
JP2013531034A5 (enExample)
JP2014505137A5 (enExample)
JP2012204203A5 (enExample)
JP2012031285A5 (enExample)
JP2012524113A5 (enExample)
JP2011214087A5 (enExample)
JP2010532807A5 (enExample)
JP2010166925A5 (enExample)
JP2011208181A5 (enExample)
JP2012193264A5 (enExample)
JP2012190699A5 (enExample)
JP2012011658A5 (enExample)
JP2011146571A5 (enExample)
JP2011233516A5 (enExample)
JP2013503915A5 (enExample)
JP2013016377A5 (enExample)
JP2012115928A5 (enExample)
JP2012524034A5 (enExample)
JP2013522131A5 (enExample)
JP2012136489A5 (enExample)